Day: October 6, 2022

BRIDGEWATER, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging anti-cancer mechanism resulting in iron-mediated cell death for drug resistant and devastating cancers, today announced that Randy Milby, Founder and Chief Executive Officer will present in-person and host one-on-one meetings with investors at the following conferences: Event: Dawson James Securities 7th Annual Small Cap Growth ConferenceDate: Wednesday, October 12, 2022Webcast: Conference Registration LinkArchived Recording: ir.hillstreambio.comTime: Please check with the conference coordinator as presentation times are subject to change.Location: Wyndham Grand Hotel in Jupiter, Florida Event: ThinkEquity...

Consolidated Bookings Approximately $2,600,000 for Month of September HAUPPAUGE, N.Y., Oct. 06, 2022 (GLOBE NEWSWIRE) — Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software solution provider, today announced that its Power Group (“OPG”), reported bookings in excess of $1,200,000 for the month of September 2022. In addition, inclusive of Orbit’s Electronics Group (“OEG”), consolidated bookings reached approximately $2,600,000 for the month. Deliveries for certain of these orders have already commenced with the majority expected to ship by the second quarter of 2023. Mitchell Binder, President and CEO of Orbit International commented, “We are pleased to report a firm booking month for our OPG with total bookings for the month of September 2022 exceeding $1,200,000. These orders were highlighted by several...

HOPEWELL JUNCTION, N.Y., Oct. 06, 2022 (GLOBE NEWSWIRE) — eMagin Corporation (NYSE American: EMAN), a leader in the development, design, and manufacture of high-resolution OLED microdisplays for AR/VR and other near-eye imaging products, today announced its chief operating officer, Dr. Amal Ghosh, will present an invited paper at the OLEDs World Summit in San Francisco, California, on October 27, 2022. Invited Paper at OLEDs World Summit Speaker: Dr. Amal Ghosh, COO, eMagin Corp. Title: OLED-on-Silicon Microdisplays Abstract: The significance of microdisplays, particularly OLED-on-Silicon microdisplays, have come to the forefront with the advent of AR/VR applications. With recent brightness and other improvements, OLED-on-Silicon microdisplays are considered the technology of choice for today’s AR/VR applications. This talk will...

ATLANTA, Oct. 06, 2022 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its third quarter 2022 financial results on Tuesday, October 25, 2022, after the stock market closes. The press release will be followed by a conference call hosted by Manhattan Associates senior management at 4:30 p.m. Eastern time, also on October 25. Investors are invited to listen to a live webcast of the conference call through the Investor Relations section of the Manhattan Associates website at ir.manh.com. To listen to the live webcast, please go to the website at least 15 minutes before the call to download and install any necessary audio software. For those who cannot listen to the live broadcast, a replay can be accessed shortly after the call by dialing +1-877-660-6853 in the U.S. and Canada, or +1-201-612-7415...

Chooses Automated Pre-Bill Coding Analysis for Inpatient and Outpatient Care Atlanta, GA, Oct. 06, 2022 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, announced today it has signed a contract with a 1,400-bed, Oracle Cerner-EHR based health system in the Mid-Atlantic region. The system will use eValuator’s automated pre- and post-bill coding analysis technology to help improve revenue integrity and financial performance from inpatient and outpatient encounters. Streamline Health is leading an industry movement to enable every hospital in the country to use pre-bill technology to improve financial performance. With eValuator, providers are identifying and addressing coding...

The microfluidics-based system accommodates scalable throughputs to address specific and evolving project needs SOUTH SAN FRANCISCO, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the launch of the X9™ Real-Time PCR System, an innovative high-capacity genomics instrument offering superior efficiency. X9 enables high data output with more than 9,000 individual nanoliter-volume reactions in a single run, ensuring cost-effective, comprehensive sample profiling with minimal operator contribution. Instead of using 96 plates worth of reagents, plastic and labor, X9 can reduce an experiment to a single integrated fluidic circuit (IFC) – a microfluidic chip. The X9 platform, powered by single-touchpoint...

BASKING RIDGE, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that management will participate in the following events:RNA USA Leaders Congress 2022 (October 18-19, 2022)Location: The Colonnade Hotel, Boston, MASession: Closing Keynote Panel: Moving Forward to Obtain Targeted Delivery, Tolerability and Expression Control of RNA TreatmentsSession Date/Time: Tuesday, October 18, 2022, at 5:20 p.m. (ET)Company Panelist: David S. Slack, MBA, President and Chief Business Officer of Lisata For more information about the RNA USA Leaders Congress, please visit https://www.lsxleaders.com/rna-leaders-usa-congress.LD...

Spod Lithium Corp. Land Package Spod Lithium Corp. Engages Japosat – Potential Pegmatites Identified – Fieldwork to BeginVANCOUVER, British Columbia, Oct. 06, 2022 (GLOBE NEWSWIRE) — SPOD LITHIUM CORP. (“SPOD” or the “Company”) (CSE: SPOD) is pleased to announce it has identified potential Pegmatites on its Megali and Lithium Grande 4 properties in the James Bay Territory. Spod engaged Japosat Satellite Mapping (“Japosat”) of Montreal, Quebec to provide analysis of satellite imagery at the Company’s Megali and Lithium Grande 4 projects, and the Company is extremely encouraged by the images received from Japosat. Japosat acquired and processed satellite imagery in order to provide detailed data identifying areas of mineral surface outcrop, areas with potential for lithium mineralization, priority...